← Back to all trials
Completed
NCT05604664
Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Escc
Conditions: Esophageal Cancer
Sex: All
Enrollment: 1727
Sponsor: Yongtao Han
Location: China
Summary
The goal of this observational study is to to clarify the focus of lymph node dissection during esophagectomy..
The main question[s] it aims to answer is:provide a basis for accurate staging and the relationship between OS and lymph node dissection
Eligibility Criteria
Inclusion Criteria:Pathologic findings proved ESCC (8th AJCC/UICC stage T1b-4aN0-3M0)Underwent esophagecomy (two-field or three-field LN dissection)The primary tumor was thoracic ESCCExclusion Criteria:Located outside the thoracicPatients underwent salvage or R1/R2 esophagecomyThe number of resected lymph nodes (RLNs) less than 15With neoadjuvant therapy(NT) or salvage chemoradiotherapy(SCRT)
Source: ClinicalTrials.gov (NCT05604664). StuddyBuddy aggregates publicly available trial information.